Afghanistan vs Macau, China: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Macau, China
100.0%
in 2024
Afghanistan rank
1st
Macau, China rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Macau, China
How they compare
Afghanistan currently reports 100.0% against 100.0% in Macau, China, a difference of 0.0%.
The two have swapped places 5 times across 12 shared years of data; in 2010 it was Afghanistan ahead.
Afghanistan ranks 1st and Macau, China ranks 1st of 144 countries.
Afghanistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Macau, China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.9% | 60.7% | 23.1% | Afghanistan |
| 2020s | 100.0% | 78.4% | 21.6% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Macau, China?
- Afghanistan, at 100.0% against 100.0% in Macau, China as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Macau, China?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Macau, China?
- 12 years are reported by both, from 2010 to 2024.
- How do Afghanistan and Macau, China rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Macau, China ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.